You have 9 free searches left this month | for more free features.

Vinorelbine

Showing 51 - 75 of 598

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Los Angeles, California
  • +24 more
Aug 10, 2022

Metastatic Breast Cancer Trial in Bratislava (Disulfiram, Vinorelbin, Cisplatin)

Recruiting
  • Metastatic Breast Cancer
  • Bratislava, Slovakia
  • +1 more
Mar 2, 2021

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

Triple Negative Breast Cancer Trial (SKB264)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Apr 20, 2022

Metastatic Breast Cancer Trial in Dallas (Anakinra plus Standard of Care)

Completed
  • Metastatic Breast Cancer
  • Anakinra plus Standard of Care
  • Dallas, Texas
    Baylor University Medical Center
Oct 7, 2021

NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

Withdrawn
  • Non-Small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +8 more
  • (no location specified)
Mar 9, 2022

Breast Cancer Trial (capecitabine and trastuzumab, vinorelbine and trastuzumab)

Not yet recruiting
  • Breast Cancer
  • capecitabine and trastuzumab
  • vinorelbine and trastuzumab
  • (no location specified)
Jun 7, 2021

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)

Recruiting
  • Multiple Myeloma
  • Vinorelbine
  • +2 more
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Cervical Cancer Trial in Algeria (Nimotuzumab ( h-R3), Placebo)

Completed
  • Cervical Cancer
  • Nimotuzumab ( h-R3)
  • Placebo
  • Algiers, Algeria
  • +4 more
Aug 22, 2021

Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,

No longer available
  • Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
  • Triple-Negative Breast Cancer
  • Seattle, Washington
    Seattle Cancer Care Allliance
Jul 14, 2021

Breast Cancer Trial in Beijing (RC48-ADC, Paclitaxel Injection, Docetaxel Injection)

Recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Oncology Hospital, Chinese Academy of Medical Sciences
Nov 24, 2021

NSCLC Trial in Denmark (Navelbine, 66 Gy/33F, 60 Gy/30F)

Completed
  • Non-small Cell Lung Cancer
  • Aalborg, Denmark
  • +5 more
Apr 22, 2022

Breast Cancer Trial (TAC, NX)

Completed
  • Breast Cancer
  • (no location specified)
Feb 2, 2021

Metastatic Breast Cancer Trial in Frankfurt am Main (Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel,

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen)
  • Frankfurt am Main, Germany
    Agaplesion Markus Krankenhaus - Klinik für Gynäkologie und Gebur
Feb 22, 2022

Non Small Cell Lung Cancer Trial (Toripalimab, Toripalimab mimetic ())

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Feb 23, 2021

Low-Grade Glioma Trial in France (ORAL VINORELBINE)

Completed
  • Low-Grade Glioma
  • ORAL VINORELBINE
  • Angers, France
  • +15 more
Nov 17, 2020

Breast Cancer Trial in Washington (docetaxel, vinorelbine ditartrate)

Completed
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Aug 12, 2020

Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Atovaquone Oral Suspension
  • +2 more
  • Edinburgh, United Kingdom
  • +1 more
Dec 21, 2021

NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
  • +2 more
  • Paris, France
  • +2 more
May 30, 2022

Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)

Completed
  • Pleural Mesothelioma Malignant Advanced
  • Barcelona, Spain
  • +14 more
Aug 23, 2022

Lymphoma Trial in Los Angeles (rituximab, vinorelbine ditartrate)

Completed
  • Lymphoma
  • rituximab
  • vinorelbine ditartrate
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Lung Cancer Trial in United States (gemcitabine HCl, paclitaxel poliglumex, vinorelbine tartrate)

Terminated
  • Lung Cancer
  • gemcitabine hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
Oct 2, 2020

Hormone Receptor Positive Advanced Breast Cancer Trial in Beijing (fluvestrant + oral vinorelbine)

Unknown status
  • Hormone Receptor Positive Advanced Breast Cancer
  • fluvestrant + oral vinorelbine
  • Beijing, Beijing, China
    National Cacner Center/ Cancer Hospital,Chinese Academy of Medic
Jun 21, 2020

Breast Cancer Trial in Cleveland (celecoxib, vinorelbine ditartrate)

Terminated
  • Breast Cancer
  • Cleveland, Ohio
    Ireland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020